Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patients with Plaque Psoriasis

Stock Information for Crescita Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.